|
12 Feb 2021
|
Quarterly Results |
- |
|
11 Nov 2020
|
Quarterly Results & A.G.M. |
- |
|
28 Aug 2020
|
Quarterly Results |
- |
|
25 Jun 2020
|
Audited Results |
- |
|
14 Feb 2020
|
Quarterly Results |
- |
|
14 Nov 2019
|
Quarterly Results & Others |
- |
|
14 Aug 2019
|
Quarterly Results |
- |
|
30 May 2019
|
Audited Results |
- |
|
14 Feb 2019
|
Quarterly Results |
- |
|
14 Nov 2018
|
Quarterly Results |
- |
|
14 Aug 2018
|
Quarterly Results & Others |
- |
|
29 May 2018
|
Audited Results |
- |
|
14 Feb 2018
|
Quarterly Results & Others |
Review of the progress of Bio Pharma Division Agri Division and Pharma Division. |
|
14 Nov 2017
|
Quarterly Results & Others |
Review of the progress of Bio Pharma Division, Agri Division & Pharma Division |
|
14 Sep 2017
|
Quarterly Results & Others |
- |
|
29 May 2017
|
Audited Results |
- |
|
14 Feb 2017
|
Quarterly Results |
- |
|
14 Nov 2016
|
Quarterly Results |
As the companys bankers PNB initiated action under SARFAESI Act and issued public auction of the Companys properties the operations of the Company are still under closure. |
|
12 Aug 2016
|
Quarterly Results & Others |
Review of the progress of Bio Pharma Division Agri Division and Pharma Division. |
|
28 May 2016
|
Quarterly Results & Others |
Review of the progress of Bio Pharma Division Agri Division and Pharma Division. |
|
13 Feb 2016
|
Quarterly Results & Others |
Review of the progress of Bio Pharma Division Agri Division and Pharma Division. |
|
12 Nov 2015
|
Quarterly Results & Others |
Review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
10 Aug 2015
|
Quarterly Results & Others |
1. To fix the date for Annual General Body Meeting. 2. Review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
28 May 2015
|
Audited Results & Others |
Review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
14 Feb 2015
|
Quarterly Results |
Review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
13 Nov 2014
|
Quarterly Results & Others |
To Review the Phase II expansion of Bio Pharma Unit & consider various funding options viz., Raising of Debt, Preferential Allotment of Equity Shares & Preferential Allotment of Warrants to promoters. |
|
14 Aug 2014
|
Quarterly Results & Others |
1. To fix the date for Annual General Body Meeting. 2. Review of the progress of Bio Pharma Division, Agri Division and Pharma Division . |
|
24 May 2014
|
Audited Results & Others |
- |
|
12 Feb 2014
|
Quarterly Results & Others |
- |
|
14 Nov 2013
|
Quarterly Results & Others |
To consider the review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
14 Aug 2013
|
Audited Results |
- |
|
29 May 2013
|
Audited Results & Others |
- |
|
11 Feb 2013
|
Quarterly Results & Others |
- |
|
12 Nov 2012
|
Quarterly Results & Others |
inter alia, to take the following : Review the progress of Bio-pharma Division, Agri Division, Pharma Division. |
|
27 Aug 2012
|
Audited Results |
- |
|
25 Jul 2012
|
Quarterly Results & Others |
inter alia, to consider : 1. Un-Audited Financial results for the quarter ended on June 30, 2012. 2. Review of the progress of Bio Pharma Division, Agri Division & and Pharma Division. |
|
12 May 2012
|
Quarterly Results & Others |
The Board shall take review of the progress of Bio Phama Division, Agri Division & Pharma Division. |
|
29 Mar 2012
|
Conversion of Share Warrants |
The Board decided not to convert any outstanding Share Warrants into Equity due to as the period of 18 months elapsed from the date of allotment i.e. July 29, 2010. |
|
25 Jan 2012
|
Quarterly Results & Others |
To review the progress of Agri Division, Pharmacy Division & Biotech Unit. |
|
31 Oct 2011
|
Quarterly Results & Others |
To consider the followings: 1. To review the progress of Agri Division; pharmacy Division and Biotech unit. 2. To approve the appointment of Whole time Company Secretary. |
|
22 Aug 2011
|
Audited Results |
- |
|
20 Jul 2011
|
Quarterly Results & Others |
- |
|
28 Apr 2011
|
Quarterly Results & Others |
To review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
29 Mar 2011
|
Conversion of Share Warrants |
To consider the conversion of Share Warrants. |
|
29 Jan 2011
|
Quarterly Results & Others |
To consider the review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
27 Oct 2010
|
Quarterly Results & Others |
- |
|
24 Aug 2010
|
Audited Results |
- |
|
28 Jul 2010
|
Quarterly Results & Others |
The Board has allotted 40,00,000 Warrants to Promoter of the Company at Rs. 10 each per Share at a premium of Rs. 10.15 each & Reviewed the progress of Bio-Pharma, Pharma and Agri Divisions. |
|
28 Apr 2010
|
Quarterly Results & Others |
Inter alia, to review of the progress of Bio Pharma Division, Agri Division and Pharma Division. |
|
29 Jan 2010
|
Quarterly Results & Others |
The Board has approved to raise funds for the on going expansion of the state of the art Bio-Pharma unit at Shameerpet & to issue 40,00,000 Conv. Share Warrants to the Promoters on preferential basis. |
|
29 Oct 2009
|
Quarterly Results & Others |
To review of the progress of Bio Pharma Division and Pharma Division & to discuss the progress of on going R&D projects for process development of Bio-Similars. |
|
26 Aug 2009
|
Audited Results & Others |
To discuss on the proposal of raising of funds through debt / capital / loan etc & to fix the dates of Book Closure. |
|
28 Jul 2009
|
Quarterly Results & Others |
inter alia, to review the progress of Bio Pharma and Pharma Division & to discuss on the progress of setting up of R & D centre in new process and formulation development. |
|
27 Apr 2009
|
Quarterly Results & Others |
inter alia, to review the progress of Bio Pharma and Pharma Division & to setup a bulk API plant at APIIC Industrial Estate Nadikudi, Guntur Dist - A.P. |
|
29 Jan 2009
|
Quarterly Results & Others |
To review the progress of Bio Pharma, Pharma Division & to consider the launch of Oncology Products in March 2009. |
|
27 Oct 2008
|
Quarterly Results & Others |
To review the progress of Bio Pharma, Pharma Division & to take a record on the extension of scheme of implementation of Bio Pharma division by about one year. |
|
31 Jul 2008
|
Quarterly Results & Others |
To raise the required funds for setting up the proposed API unit, Pharmaceuticals formulations unit of US FDA compliance & authorized the managing director to take necessary steps. |
|
04 Apr 2008
|
Quarterly Results |
- |
|
30 Jan 2008
|
Quarterly Results & Others |
inter alia, to review the progress of Bio Pharma and Pharma Division. |
|
31 Oct 2007
|
Quarterly Results & Others |
To review the progress of Bio Pharma and Pharma Division. |
|
30 Jul 2007
|
Audited Results & Quarterly Results |
To review the progress of Bio Pharma and Pharma Division |
|
30 Apr 2007
|
Quarterly Results |
- |